nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of delayed onset immune-related optic neuritis after combined immunotherapy treatment for metastatic melanoma
|
Beselaar, Z. |
|
|
2 |
S1 |
p. |
artikel |
2 |
Adjuvant lymph node radiotherapy and immunotherapy in stage III melanoma
|
Marxgut, L. |
|
|
2 |
S1 |
p. |
artikel |
3 |
Adjuvant therapy for Asian patients with resected stage III/IV BRAF V600-mutant melanoma with more than 3 years of follow-up: A multicenter retrospective study in Japan
|
Namikawa, K. |
|
|
2 |
S1 |
p. |
artikel |
4 |
Adverse Effects in Elderly Patients (≥ 85 years old) with Advanced Basal Cell Carcinoma Treated with Sonidegib: A multicenter retrospective study
|
Martos-Cabrera, L. |
|
|
2 |
S1 |
p. |
artikel |
5 |
Age over 90 years is an unfavorable prognostic factor for resectable cutaneous squamous cell carcinoma
|
Saito-Sasaki, N. |
|
|
2 |
S1 |
p. |
artikel |
6 |
ALDH1A3-acetaldehyde potentiates melanoma heterogeneity
|
Patton, E.E. |
|
|
2 |
S1 |
p. |
artikel |
7 |
All-trans retinoic acid activity in Merkel cell carcinoma cells: implication of the retinoid pathway
|
Mazziotta, C. |
|
|
2 |
S1 |
p. |
artikel |
8 |
AMBRA1 is a predictive biomarker of melanoma response to targeted therapy
|
Di Leo, L. |
|
|
2 |
S1 |
p. |
artikel |
9 |
A Multicenter Prospective Study of Electronic Skin Surface Brachytherapy for Keratinocyte Carcinoma: Long-term Follow Up and Correlation with Reflectance Confocal Microscopy
|
Barker, C. |
|
|
2 |
S1 |
p. |
artikel |
10 |
ANALYSIS OF GLOBAL Skin-Cancer Epidemiology and Correlation with Dermatologist Density and Population Risk Factors
|
Salah, S. |
|
|
2 |
S1 |
p. |
artikel |
11 |
Analysis of risk factors in melanoma survivors for the development of non-melanoma skin cancer
|
Luque-Luna, M. |
|
|
2 |
S1 |
p. |
artikel |
12 |
Analysis of the long-term survival of patients with thin melanomas using comprehensive, population-based Australian data
|
Varey, A.H. |
|
|
2 |
S1 |
p. |
artikel |
13 |
Anhidrotic ectodermal dysplasia with multiple cutaneous squamous cell carcinomas in sun-exposed areas
|
Isei, T. |
|
|
2 |
S1 |
p. |
artikel |
14 |
A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma
|
Kaczmar, J. |
|
|
2 |
S1 |
p. |
artikel |
15 |
A phase 3 study of the efficacy, safety, and pharmacokinetics profile of subcutaneous vs intravenous nivolumab + relatlimab fixed-dose combination in previously untreated metastatic or unresectable melanoma (RELATIVITY-127)
|
Long, G.V. |
|
|
2 |
S1 |
p. |
artikel |
16 |
A Randomized, Double-Blind, Phase 2 Study of Perioperative MK-4280A (Coformulation of Favezelimab and Pembrolizumab) vs Pembrolizumab in Patients With Resectable Cutaneous Squamous Cell Carcinoma
|
Schadendorf, D. |
|
|
2 |
S1 |
p. |
artikel |
17 |
A retrospective multicenter study on the real-world efficacy of chemotherapy in 204 Japanese patients with advanced extra-mammary Paget's disease
|
Miyashita, A. |
|
|
2 |
S1 |
p. |
artikel |
18 |
Assessment of facial pigmented lesions using Line-field Confocal Optical Coherence Tomography and its correlation with Reflectance Confocal Microscopy and histopathology
|
Lenoir, C. |
|
|
2 |
S1 |
p. |
artikel |
19 |
Assessment of performance in clinical risk prediction tools for cutaneous melanoma in the UK population
|
Manton, R. |
|
|
2 |
S1 |
p. |
artikel |
20 |
Assessment of the impact of a dermoscopy training associated with an artificial intelligence on general practitioner residents
|
Dorado Cortez, C. |
|
|
2 |
S1 |
p. |
artikel |
21 |
A successful treatment of locally advanced squamous cell carcinoma with cemiplimab in a patient with multiple myeloma
|
Ferreira, M.C.C. |
|
|
2 |
S1 |
p. |
artikel |
22 |
A systematic review of changes in melanocytic naevi during immune checkpoint inhibition and targeted therapy
|
Bruijn, T.V.M. |
|
|
2 |
S1 |
p. |
artikel |
23 |
Atypical granular cell tumor - a case for worry?
|
Long, S.V. |
|
|
2 |
S1 |
p. |
artikel |
24 |
Atypical spitzoid lesions: A molecular and histological analysis of two NTRK driven cases
|
Teufer, M. |
|
|
2 |
S1 |
p. |
artikel |
25 |
Augmented intelligence using 2D and 3D total body photography for melanoma screening: Patient and dermatologist perspectives in real-world application
|
Goessinger, E. |
|
|
2 |
S1 |
p. |
artikel |
26 |
Autoimmune Bullous Disorders induced by Cyclin-Dependent Kinase 4/6 inhibitors – first case series from the EADV Task Force “Dermatology for Cancer Patients”
|
Ortiz Brugués, A. |
|
|
2 |
S1 |
p. |
artikel |
27 |
Benefit of immunotherapy for advanced melanoma in two patients with xeroderma pigmentosum
|
Rivas Segovia, A.C. |
|
|
2 |
S1 |
p. |
artikel |
28 |
Beyond tropical verrucose syndrome: new associations of skin cancer and verrucous lesions
|
Peñaranda, E. |
|
|
2 |
S1 |
p. |
artikel |
29 |
BRCA1-associated-protein 1 tumour predisposition syndrome (BAP1-TPDS) presenting with multiple BAP1-inactivated melanocytic tumours – a rare hereditary tumour syndrome
|
Loh, C.H. |
|
|
2 |
S1 |
p. |
artikel |
30 |
Breslow thickness depends significantly on the individual suspecting melanoma: the importance of guaranteeing access to a dermatologist
|
López-Pardo Rico, M. |
|
|
2 |
S1 |
p. |
artikel |
31 |
Cancers of the skin and mucous membranes in people living with HIV compared to the general population
|
Ciccarese, G. |
|
|
2 |
S1 |
p. |
artikel |
32 |
Cell cannibalism: a possible source of therapy resistant melanoma-fibroblast hybrids
|
German, P. |
|
|
2 |
S1 |
p. |
artikel |
33 |
Cellular Origin of Basal Cell Carcinoma via Reflectance Confocal Microscopy
|
Ambrosio, L. |
|
|
2 |
S1 |
p. |
artikel |
34 |
Cemiplimab Immunotherapy in the Treatment of Cutaneous Squamous Cell Carcinoma
|
Kozéki, Z. |
|
|
2 |
S1 |
p. |
artikel |
35 |
Cemiplimab in the treatment of locally advanced cutaneous squamous cell carcinoma: a case series study
|
Pradeau, M.A. |
|
|
2 |
S1 |
p. |
artikel |
36 |
Changes in the pigmentation of melanocytic nevi associated with the use of self-tanners: a diagnostic challenge in patients at risk of melanoma
|
Camiña-Conforto, G. |
|
|
2 |
S1 |
p. |
artikel |
37 |
Characterization of 10 cutaneous tumors with ex vivo LC-OCT: A novel tool in dermato-oncological surgery with margin control?
|
Rosés Gibert, P. |
|
|
2 |
S1 |
p. |
artikel |
38 |
Circulating tumor DNA: a promising biomarker in stage III BRAF+ melanoma
|
Roccuzzo, G. |
|
|
2 |
S1 |
p. |
artikel |
39 |
Clinical and dermatoscopic features of multiple piloleiomyomas - a case report
|
Słomiak-Wąsik, A. |
|
|
2 |
S1 |
p. |
artikel |
40 |
Clinical characteristics and surgical approach of patient with SAMPUS/ Melanoma and pleomorphic dermal sarcoma on face
|
Petrovic Popovic, D. |
|
|
2 |
S1 |
p. |
artikel |
41 |
Clinical features and treatment patterns of patients with classic Kaposi sarcoma in Greece
|
Kokkali, S. |
|
|
2 |
S1 |
p. |
artikel |
42 |
Clinical response to immune checkpoint inhibitors in immunocompromised patient with metastatic non-melanoma skin cancer
|
Morales, P. Díaz |
|
|
2 |
S1 |
p. |
artikel |
43 |
Comparative Analysis of Pembrolizumab Dosing Schedules in the Adjuvant Treatment of Malignant Melanoma
|
Ahmed, Y. |
|
|
2 |
S1 |
p. |
artikel |
44 |
Comparison of the efficacy of skin examination using 3D total body photography to clinical and dermoscopic examination
|
Gellrich, F.F. |
|
|
2 |
S1 |
p. |
artikel |
45 |
Complete regression of Bowen's disease after incisional biopsy: case report
|
Cespede, M. |
|
|
2 |
S1 |
p. |
artikel |
46 |
Complete remission of malignant lung metastasis of melanoma with stereotacticradiotherapy (Case report)
|
Danyi, T. |
|
|
2 |
S1 |
p. |
artikel |
47 |
Complete response as prognostic marker of prolonged survival in metastatic melanoma
|
Bafaloukos, D. |
|
|
2 |
S1 |
p. |
artikel |
48 |
Cost -effectiveness of Surgical Excision versus Photodynamic Therapy and 5-Fluorouracil Cream in Treatment of Bowen’s Disease: a trial based economic evaluation
|
Ahmady, S. |
|
|
2 |
S1 |
p. |
artikel |
49 |
Cost-of-illness of skin cancer: A systematic review
|
Meertens, A. |
|
|
2 |
S1 |
p. |
artikel |
50 |
Cumulative sum analysis-integrated e-learning for differentiation between basal cell carcinoma and non-basal cell carcinoma on optical coherence tomography: a diagnostic cohort study
|
Wolswijk, T. |
|
|
2 |
S1 |
p. |
artikel |
51 |
Delphi Consensus of Tumor Stage Based Treatment Approach to High-Risk Cutaneous Squamous Cell Carcinoma
|
Patel, V. |
|
|
2 |
S1 |
p. |
artikel |
52 |
Dermatological adverse events due to oncotherapy: the necessity for a new classification
|
Pagani, A. |
|
|
2 |
S1 |
p. |
artikel |
53 |
Dermoscopic, Reflectance Confocal Microscopy and Line-field Optical Coherence Tomography features of Cutaneous Lymphomas
|
D'onghia, M. |
|
|
2 |
S1 |
p. |
artikel |
54 |
Dermoscopy of basal cell carcinoma explained by line-field confocal optical coherence tomography: preliminary results of a correlation study
|
Azahaf, A. |
|
|
2 |
S1 |
p. |
artikel |
55 |
Desmoplasia, a risk factor for recurrence and metastasis in cutaneous squamous cell carcinoma: an interobserver agreement study among dermatopathologists
|
Crüts, E. |
|
|
2 |
S1 |
p. |
artikel |
56 |
Developing a patient-informed conceptual model of advanced and metastatic melanoma
|
McFadden, S. |
|
|
2 |
S1 |
p. |
artikel |
57 |
Diagnosis of vulvar pigmented lesions with confocal microscopy
|
Valenti, M. |
|
|
2 |
S1 |
p. |
artikel |
58 |
Diagnostic criteria for melanocytic lesions in LC-OCT
|
Pérez-Anker, M.J. |
|
|
2 |
S1 |
p. |
artikel |
59 |
Discoidin domain receptor 1, a melanoma immunomodulator
|
Lutz, C. |
|
|
2 |
S1 |
p. |
artikel |
60 |
Does the interval between melanoma diagnosis and surgery have an impact on outcomes? A systematic review and meta-analysis
|
Strazda, A.E. |
|
|
2 |
S1 |
p. |
artikel |
61 |
Dupilumab for the treatment of bullous pemphigoid triggered by melanoma immunotherapy
|
Tsentemeidou, A. |
|
|
2 |
S1 |
p. |
artikel |
62 |
Early detection of skin cancer: a nurse-initiated consultation to improve dermatology access
|
Shen, A. |
|
|
2 |
S1 |
p. |
artikel |
63 |
Early recurrence in a pooled international cohort of melanoma patients treated with adjuvant nivolumab in a real-world setting
|
Mortier, L. |
|
|
2 |
S1 |
p. |
artikel |
64 |
Effects of temozolomide on tumor mutation burden and microsatellite instability in melanoma cells
|
Sawada, M. |
|
|
2 |
S1 |
p. |
artikel |
65 |
Efficacy and safety of tirbanibulin 1% ointment for the treatment of actinic keratosis in routine clinical practice in Spain and Italy (TIRBASKIN study)
|
Gilaberte, Y. |
|
|
2 |
S1 |
p. |
artikel |
66 |
Elevating MAPK Pathway Suppression with Combinatorial ERK Inhibitors
|
Kosnopfel, C. |
|
|
2 |
S1 |
p. |
artikel |
67 |
Enhancement of sun-damaged skin qualities with tirbanibulin (SunDamage Study)
|
Kopera, D. |
|
|
2 |
S1 |
p. |
artikel |
68 |
Epidemiological indicators of melanoma in the Republic of Uzbekistan
|
Ibragimova, D. |
|
|
2 |
S1 |
p. |
artikel |
69 |
Estimating Occupational Exposure to Ultraviolet Radiation Using the Canadian Occupation Exposure Matrix (CANJEM) in a Nationwide Cohort of French Adults
|
Amari, B. |
|
|
2 |
S1 |
p. |
artikel |
70 |
Evaluating the performance of a clinicopathological prognostic nomogram and utility of the 40-gene expression profile (40-GEP) test in refining risk of metastasis in high-risk cutaneous squamous cell carcinoma (HR-cSCC) patients
|
Jambusaria-Pahlajani, A. |
|
|
2 |
S1 |
p. |
artikel |
71 |
Evaluation of anticancer therapy- related dermatologic adverse events: insights from fda's faers dataset
|
Salah, S. |
|
|
2 |
S1 |
p. |
artikel |
72 |
Evaluation of efficacy and tolerability of a repairing protective cream containing the postbiotic Aquaphilus Dolomiae extract G2 for onco-dermatological indications
|
Stennevin, A. |
|
|
2 |
S1 |
p. |
artikel |
73 |
Examining the Association Between Ruxolitinib and Aggressive Cutaneous Squamous Cell Carcinoma: Is There a Justified Need for Screening Programs?
|
Gruber-Velasco, F. |
|
|
2 |
S1 |
p. |
artikel |
74 |
Exceptional response to rechallenge of BRAF/MEK inhibitors in patients with primary acquired resistance to targeted therapy
|
Ziółkowska, B. |
|
|
2 |
S1 |
p. |
artikel |
75 |
Exploring “Decision regret” in Adjuvant-Treated Melanoma Patients– results from a cross-sectional survey on 200 participants
|
Grünke, T. |
|
|
2 |
S1 |
p. |
artikel |
76 |
Factors Influencing the Risk of Involved and Close Squamous Cell Carcinoma Excision and Recurrence: A Comprehensive Analysis over a 7-Year Period
|
Patel, M.K. |
|
|
2 |
S1 |
p. |
artikel |
77 |
First description of atypical fibroxanthoma in Line-Field Confocal Optical Coherence Tomography and comparison with Reflectance Confocal Microscopy
|
Lenoir, C. |
|
|
2 |
S1 |
p. |
artikel |
78 |
First-line Nivolumab plus Ipilimumab in patients with advanced melanoma previously treated with adjuvant systemic therapy
|
Kisielewska, K. |
|
|
2 |
S1 |
p. |
artikel |
79 |
Flow cytometry-based strategy to characterize the microenvironment of skin tumors as a tool for preclinical research
|
Reyes-Garau, D. |
|
|
2 |
S1 |
p. |
artikel |
80 |
Four years experience in Mohs Surgery
|
Greco, A.G. |
|
|
2 |
S1 |
p. |
artikel |
81 |
Gamification of Dermoscopy Education Using a Smartphone Mobile Platform: A Pilot Study
|
Aponso, S. |
|
|
2 |
S1 |
p. |
artikel |
82 |
Gastric Melanoma: Primary or Secondary Forms? 2 case reports
|
Hanis, C. |
|
|
2 |
S1 |
p. |
artikel |
83 |
Gene Signatures predict immune-related skin adverse events in melanoma patients
|
Mallardo, D. |
|
|
2 |
S1 |
p. |
artikel |
84 |
Genetic sequencing and Novel Therapeutic Targets in Perianal Extramammary Paget Disease
|
Lavin, L. |
|
|
2 |
S1 |
p. |
artikel |
85 |
High dose Vitamin D supplementation does not improve outcome in a cutaneous melanoma population: results of randomized a double-blind, placebo-controlled study (ViDMe trial)
|
De Smedt, J. |
|
|
2 |
S1 |
p. |
artikel |
86 |
Higher intraoperative detection rate of suspicious non-palpable lesions using wire marking in skin cancer patients
|
Tietze, J.K. |
|
|
2 |
S1 |
p. |
artikel |
87 |
Histopathologic Correlation of Structures Seen in Super High Magnification Dermoscopy of Basal Cell Carcinoma
|
Pogorzelska-Dyrbuś, J. |
|
|
2 |
S1 |
p. |
artikel |
88 |
HPV vaccination practices among organ transplant recipients in France
|
de Quatrebarbes, J. |
|
|
2 |
S1 |
p. |
artikel |
89 |
Hypertrophic Lichen Planus associated with Pembrolizumab
|
Sato-Sano, M. |
|
|
2 |
S1 |
p. |
artikel |
90 |
Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysis
|
Amaral, T. |
|
|
2 |
S1 |
p. |
artikel |
91 |
Identification of two transcriptomic subgroups in actinic keratosis: differentiation between normal skin and cutaneous squamous cell carcinoma-like profiles using RNA-seq
|
Corchete-Sánchez, L. |
|
|
2 |
S1 |
p. |
artikel |
92 |
IL-17 mediates angiogenesis in Basal Cell Carcinomas and Squamous Cell Carcinomas
|
Cunha, D. |
|
|
2 |
S1 |
p. |
artikel |
93 |
Imaging in Locally Advanced and Metastatic Basal Cell Carcinoma: Findings and Recommendations
|
Zwanenburg, A. |
|
|
2 |
S1 |
p. |
artikel |
94 |
Immune-related adverse events with adjuvant anti-PD-1 therapy in high-risk resected melanoma: a single-center experience
|
Csányi, I. |
|
|
2 |
S1 |
p. |
artikel |
95 |
Immunohistochemical analysis of AMBRA1 and loricrin expression reveals maintained expression in the epidermis overlying a range of benign melanocytic naevi but which may be altered in some melanoma in situ cases
|
Husain, A. |
|
|
2 |
S1 |
p. |
artikel |
96 |
Immunotherapy after progression to immunotherapy: Pembrolizumab and Lenvatinib versus conventional chemotherapy for patients with metastatic melanoma after failure of PD-1/CTLA-4 inhibition
|
Lyrarakis, G. |
|
|
2 |
S1 |
p. |
artikel |
97 |
Impact of Immune-Related Adverse Events on Melanoma Outcomes: A Comprehensive Analysis
|
Ahmed, Y. |
|
|
2 |
S1 |
p. |
artikel |
98 |
Incidence and surgical treatment trends of non-melanoma skin cancer in Denmark 2002-2021
|
Holdam, A.S.K. |
|
|
2 |
S1 |
p. |
artikel |
99 |
Incidence, local recurrence, metastasis, disease-specific survival, and overall survival in patients with cutaneous rhabdomyosarcoma: A nationwide cohort study of 24 patients
|
Dueled, S.H. |
|
|
2 |
S1 |
p. |
artikel |
100 |
Incidence Of Skin Melanoma And Mortality From It Among The Population Of The Republic Of Belarus (epidemiological data from a 30-year study)
|
Prakoshyn, A. |
|
|
2 |
S1 |
p. |
artikel |
101 |
Insights on different erythroderma features in Sezary syndrome: a prospective validation study
|
Roccuzzo, G. |
|
|
2 |
S1 |
p. |
artikel |
102 |
Integrated transcriptomics reveals cellular and molecular interactions in pruritic cutaneous T-cell lymphoma
|
Roggo, A. |
|
|
2 |
S1 |
p. |
artikel |
103 |
Integrating a Clinicopathological Risk Prediction Model into the European Guideline for Cutaneous Squamous Cell Carcinoma
|
Steijlen, O. |
|
|
2 |
S1 |
p. |
artikel |
104 |
Interim analysis of the multinational, post-authorisation safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma: Time to onset of adverse events
|
Gutzmer, R. |
|
|
2 |
S1 |
p. |
artikel |
105 |
InterPATH-001 trial in progress: Adjuvant V940 (mRNA-4157) with pembrolizumab versus placebo in patients with high-risk stage II-IV melanoma
|
Weber, J.S. |
|
|
2 |
S1 |
p. |
artikel |
106 |
Ipilimumab and nivolumab in uveal melanoma: report on toxicity and treatment intensity
|
Ciernik, A. |
|
|
2 |
S1 |
p. |
artikel |
107 |
Is melanoma a death sentence in Black Africans? A three-year institutional study from a resource limited setting
|
Adoke, K. |
|
|
2 |
S1 |
p. |
artikel |
108 |
Is There a Distinctive Molecular Identity for Sinonasal Malignant Mucosal Melanoma Compared to Cutaneous Melanoma?
|
Molina-García, M. |
|
|
2 |
S1 |
p. |
artikel |
109 |
Kindlin-3 inactivation mediates melanoma agressiveness through crosstalk with the collagen-activated tyrosine kinase receptor DDR1
|
Reger de Moura, C. |
|
|
2 |
S1 |
p. |
artikel |
110 |
Kissing lesions on penis – a very rare case report
|
Buljan, M. |
|
|
2 |
S1 |
p. |
artikel |
111 |
Leg lymphoma not leg type lymphoma
|
Mercader Salvans, J. |
|
|
2 |
S1 |
p. |
artikel |
112 |
Level of satisfaction with treatment and clinical care at the Skin Cancer Unit in patients with cutaneous melanoma - A single specialist referral centre analysis
|
Ziętek, M. |
|
|
2 |
S1 |
p. |
artikel |
113 |
Localized multiple spiradenomas are caused by somatic mosaicism in ALPK1 hotspot mutation
|
Hirano-Lotman, Y. |
|
|
2 |
S1 |
p. |
artikel |
114 |
Long-term survival of melanoma patients according to primary tumour thickness – an Australian population-based study
|
Varey, A.H. |
|
|
2 |
S1 |
p. |
artikel |
115 |
Loss of AMBRA1 expression in the tumour endothelium as a potential biomarker to identify AJCC stage I/II melanomas at high risk of metastasis
|
Lovat, P. |
|
|
2 |
S1 |
p. |
artikel |
116 |
Lymph Node Operative Experience in the UK – What’s Changed?
|
Jones, O. |
|
|
2 |
S1 |
p. |
artikel |
117 |
Macrophages: A Key Population for the Resistance Acquisition in BRAF Mutant Melanoma
|
Sisó Camarasa, P. |
|
|
2 |
S1 |
p. |
artikel |
118 |
Malignant transformation during anti-TNF treatment of Hidradenitis suppurativa
|
Rudzikaite-Fergize, G. |
|
|
2 |
S1 |
p. |
artikel |
119 |
Management and outcomes following the first cutaneous squamous cell carcinoma in kidney transplant recipients: the United Kingdom COAST (Contemporary Outcomes After cutaneous SCC in Transplant recipients) study
|
Peleva, E. |
|
|
2 |
S1 |
p. |
artikel |
120 |
Management of muscle spasms induced by sonidegib in a 93-year-old patient with a multimodal gait disorder
|
Helf, C. |
|
|
2 |
S1 |
p. |
artikel |
121 |
Measuring health-related quality of life in patients with keratinocyte carcinoma: A multicenter cross-sectional study
|
Meertens, A. |
|
|
2 |
S1 |
p. |
artikel |
122 |
Melanoma Diagnostic Accuracy in a Total Body Photography System with an AI Dermoscopy App
|
Drugge, R. |
|
|
2 |
S1 |
p. |
artikel |
123 |
Melanoma in Children, Adolescents, and Young Adults: The Spanish Cohort of the MELCAYA Consortium
|
Patricio da Silva-Junior, R.M. |
|
|
2 |
S1 |
p. |
artikel |
124 |
Melanoma Prognosis and Associated Risk Factors: A Retrospective Cohort Study Using Semantic Map Analysis
|
Zahn, C.A. |
|
|
2 |
S1 |
p. |
artikel |
125 |
Merkel cell carcinoma cells proliferation is inhibited by the DNA methyltransferases inhibitor guadecitabine via methylome modulation
|
Rotondo, J.C. |
|
|
2 |
S1 |
p. |
artikel |
126 |
miR-146a-5p and miR-21-5p as Potential Biomarkers of Malignant Melanoma
|
Venturi, F. |
|
|
2 |
S1 |
p. |
artikel |
127 |
Multimodal skin imaging of a dermatofibrosarcoma protuberans using line-field confocal optical coherence tomography, ultra-high frequency ultrasound and reflectance confocal microscopy
|
Boussingault, L. |
|
|
2 |
S1 |
p. |
artikel |
128 |
Nationwide study of the treatment options of lentigo maligna and recurrence rates in the Netherlands
|
Zoutendijk, J. |
|
|
2 |
S1 |
p. |
artikel |
129 |
Neoadjuvant Vismodegib plus Mohs surgery for locally advanced periocular basal cell carcinoma. Real world scenario
|
Gonzalez, A. |
|
|
2 |
S1 |
p. |
artikel |
130 |
Neutrophil-lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to Cemiplimab treatment – a real-life setting
|
Ciobotariu, I. |
|
|
2 |
S1 |
p. |
artikel |
131 |
New designed, non-invasive diagnostic tools for the diagnosis of oral mucosal lesions
|
Ardigo, M. |
|
|
2 |
S1 |
p. |
artikel |
132 |
New differential diagnosis of melanoma. ¿Induced?
|
Peñaranda Contreras, E.O. |
|
|
2 |
S1 |
p. |
artikel |
133 |
New digital imaging technique for the follow-up of locally advanced basal cell carcinoma treated with systemic therapy
|
Di Stefani, A. |
|
|
2 |
S1 |
p. |
artikel |
134 |
Next generation sequencing (NGS) in melanoma patients: a descriptive study of a Canarian cohort with suspected cutaneous melanoma-dominant syndrome
|
Castro Gonzalez, E.N. |
|
|
2 |
S1 |
p. |
artikel |
135 |
Novel, non-invasive method for classification of melanocytic lesions using a direct illumination multispectral imaging camera
|
Goessinger, E. |
|
|
2 |
S1 |
p. |
artikel |
136 |
“One spot check”; a new strategy to increase dermatology access for worrisome skin lesions
|
Kips, J. |
|
|
2 |
S1 |
p. |
artikel |
137 |
Optimizing Healing: Evaluating Ozone Therapy's Impact on Skin Cancer Surgery Reconstruction at the Amazon Head and Neck Surgery Center
|
Feltrim, E. |
|
|
2 |
S1 |
p. |
artikel |
138 |
Paediatric Spitzoid Neoplasms: a 10-year retrospective study
|
Herzum, A. |
|
|
2 |
S1 |
p. |
artikel |
139 |
Patient and physician-reported outcomes with tirbanibulin 1% ointment for actinic keratosis in routine clinical practice in Spain and Italy (TIRBASKIN study)
|
Gilaberte, Y. |
|
|
2 |
S1 |
p. |
artikel |
140 |
Patient-orientated evaluation of treatment of non-melanoma skin cancer with Rhenium-188 compared to surgery
|
Tietze, J.K. |
|
|
2 |
S1 |
p. |
artikel |
141 |
Patient reported outcomes in the multidisciplinary treatment of patients with high-risk cutaneous squamous cell carcinoma in the head-neck area
|
Crüts, E. |
|
|
2 |
S1 |
p. |
artikel |
142 |
Patients who forego sentinel lymph node biopsy after 31-GEP testing are not harmed: A prospective, multicenter analysis
|
Guenther, J.M. |
|
|
2 |
S1 |
p. |
artikel |
143 |
Patient treatment preferences in unresectable/metastatic BRAF-mutated melanoma: a qualitative study
|
Amaral, T. |
|
|
2 |
S1 |
p. |
artikel |
144 |
Patient with metatypical metastatic Basal Cell Carcinoma treated with Vismodegib
|
Amarillo, D. |
|
|
2 |
S1 |
p. |
artikel |
145 |
PBX1 deregulation promotes melanoma progression and metastasis through alternative splicing
|
Sui, Y. |
|
|
2 |
S1 |
p. |
artikel |
146 |
Pembrolizumab treatment for advanced pleomorphic dermal sarcoma, a three-case series in a spanish tertiary-level hospital
|
Cheuque, R.P. Román |
|
|
2 |
S1 |
p. |
artikel |
147 |
Performance of a new classification system based on the eight most relevant prognostic factors for cutaneous squamous cell carcinoma: a retrospective cohort study showing limits to risk stratification with clinical and histopathological risk factors
|
Cardona-Machado, C. |
|
|
2 |
S1 |
p. |
artikel |
148 |
Perineural invasion for risk stratification in cutaneous squamous cell carcinoma: a scoping review
|
Moermans, M. |
|
|
2 |
S1 |
p. |
artikel |
149 |
Phase 2 Study of aTezolizumab, bevAcizumab, and Cobinetinib (TACo) in patients (pts) with PD1 refractory metastatic brain metastases (MBM)
|
Burton, E. |
|
|
2 |
S1 |
p. |
artikel |
150 |
Phase 2 study of intratumoral vidutolimod in combination with intravenous cemiplimab in patients with selected advanced cancer or metastatic cancer: trial in progress
|
Bhatia, S. |
|
|
2 |
S1 |
p. |
artikel |
151 |
Phenocopies in melanoma families with germline mutations in CDKN2A are associated to MC1R polymorphisms and high total body nevus count
|
Luna, A. |
|
|
2 |
S1 |
p. |
artikel |
152 |
Porokeratosis Ptychotropica: The risk of cancerization and treatment options
|
Loh, C.H. |
|
|
2 |
S1 |
p. |
artikel |
153 |
Predicting sentinel node positivity in patients with primary cutaneous melanoma: an international multicentre study validating and refining the MIA risk calculator
|
Varey, A.H. |
|
|
2 |
S1 |
p. |
artikel |
154 |
Prediction of melanoma metastasis using dermatoscopy deep features. An international multicenter cohort study
|
Lallas, K. |
|
|
2 |
S1 |
p. |
artikel |
155 |
Predictors of recurrence and progression in poorly differentiated cutaneous squamous cell carcinomas: insights from a real-life experience
|
Roccuzzo, G. |
|
|
2 |
S1 |
p. |
artikel |
156 |
Pregnancy-associated melanoma- a pilot study
|
Buljan, M. |
|
|
2 |
S1 |
p. |
artikel |
157 |
Pre-treatment with topical tirbanibulin of surrounding Non Melanoma Skin Cancer cancerization field to improve surgical outcome
|
Gualdi, G. |
|
|
2 |
S1 |
p. |
artikel |
158 |
Primary radiotherapy in older adults with basal cell carcinoma: results of the prospective, multicenter BATOA cohort study on treatment burden, short-term outcomes and a comparison with surgically treated patients
|
Mangnus, J.E. |
|
|
2 |
S1 |
p. |
artikel |
159 |
Prognostic factors for treatment failure of photodynamic therapy and5-fluorouracil in Bowen’s disease
|
Ahmady, S. |
|
|
2 |
S1 |
p. |
artikel |
160 |
Prognostic impact of the surgical deep margin distance of invasive acral melanoma of the sole: A multi-institutional retrospective study
|
Koizumi, S. |
|
|
2 |
S1 |
p. |
artikel |
161 |
Prognostic significance of sentinel node tumor burden in Merkel Cell Carcinoma
|
Zijlker, L. |
|
|
2 |
S1 |
p. |
artikel |
162 |
Prognostic value of tumor microenvironment molecules in the response to immunotherapy in advanced melanoma
|
Parra-Navarro, L. |
|
|
2 |
S1 |
p. |
artikel |
163 |
Prospective multicenter comparative study of dermoscopic images of a standard dermatoscope and an Autonomous TBP/Dermoscopic Imaging device (DeviskanR) ("Deviskan QS"-Quality Study)
|
Malvehy, J. |
|
|
2 |
S1 |
p. |
artikel |
164 |
Proteomic Profiling of Cutaneous Squamous Cell Carcinoma Samples from Solid Organ Transplant Recipients and Immunocompetent Patients
|
Azimi, A. |
|
|
2 |
S1 |
p. |
artikel |
165 |
Psychological distress and need for psycho-oncological support in high-risk patients for melanoma and melanoma survivors: Patient-reported outcomes of a prospective study
|
Mueller, A.M. |
|
|
2 |
S1 |
p. |
artikel |
166 |
Quality-of-Life Assessment in Spanish Stage III Immunotherapy Patients: A Prospective Observational Study
|
Crespí-Payeras, F. |
|
|
2 |
S1 |
p. |
artikel |
167 |
Radioimmunotherapy Sequence Impact on Clinical Outcomes of Patients with Melanoma Brain Metastases: A Meta-analysis of Comparative Studies
|
Haddad, P. |
|
|
2 |
S1 |
p. |
artikel |
168 |
Real-World Evaluation of ImmuCare Patient-Reported Outcomes in Melanoma Patients Treated with Immune-Checkpoint Inhibitors
|
Belkaïd, S. |
|
|
2 |
S1 |
p. |
artikel |
169 |
Real-world outcomes for advanced melanoma in the adjuvant and unresectable setting: Single-center registry analysis
|
Staeger, R. |
|
|
2 |
S1 |
p. |
artikel |
170 |
Real-world outcomes of adjuvant therapy in melanoma: an Italian referral center experience
|
Roccuzzo, G. |
|
|
2 |
S1 |
p. |
artikel |
171 |
Redefine Individual Melanoma Patient Stratification with Artificial Intelligence and Computational Analysis
|
Ficapal, J. |
|
|
2 |
S1 |
p. |
artikel |
172 |
RESCUE STUDY – International Survey on training of Dermatology Residents in Supportive Oncodermatology
|
Ortiz Brugués, A. |
|
|
2 |
S1 |
p. |
artikel |
173 |
Right-Sided Lateralisation of Basal Cell Carcinoma and Squamous Cell Carcinoma in a UK Cohort
|
Tao, C. |
|
|
2 |
S1 |
p. |
artikel |
174 |
Risk factors on developing brain metastasis from melanoma: A sistematic review
|
Freitas, M. |
|
|
2 |
S1 |
p. |
artikel |
175 |
RNA helicase DHX9 enables PBX1 mRNA translation by unfolding RNA G-quadruplex in melanoma
|
Sui, Y. |
|
|
2 |
S1 |
p. |
artikel |
176 |
Role of eIF6 in Modulating Response to BRAF Inhibitors and Acquired Resistance in Cutaneous Melanoma
|
Kyriakopoulos, G. |
|
|
2 |
S1 |
p. |
artikel |
177 |
Role of the COVID-19 pandemic on the incidence and stage at initial diagnosis of cutaneous melanoma: a retrospective national study from the French Clinical Database of Melanoma Patients (RIC-Mel)
|
Skowron, F. |
|
|
2 |
S1 |
p. |
artikel |
178 |
Sarcopenia as a prognostic indicator in advanced melanoma; a retrospective cohort study
|
McCrossan, S. |
|
|
2 |
S1 |
p. |
artikel |
179 |
Sex differences and its impact on treatment outcomes of advanced melanoma in Germany – a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG
|
Leven, A.-S. |
|
|
2 |
S1 |
p. |
artikel |
180 |
Single-cell and spatial transcriptomic analysis of primary (nevus-associated)-melanoma
|
van de Haar, L. |
|
|
2 |
S1 |
p. |
artikel |
181 |
Skin adnexal carcinomas DNA genomic profiling uncovers oncogenic pathways and potential therapeutic targets
|
Louveau, B. |
|
|
2 |
S1 |
p. |
artikel |
182 |
Skin and Ultraviolet Neoplasia Transplant Risk Assessment Calculator (SUNTRAC): Perspectives from the EUSCAP database in a cohort of kidney transplant recipients
|
Al Bouzidi, W. |
|
|
2 |
S1 |
p. |
artikel |
183 |
Slow Mohs Micrographic Surgery: A Service Evaluation
|
Reid, N. |
|
|
2 |
S1 |
p. |
artikel |
184 |
Slow Mohs Micrographic Surgery in the management of Extramammary Paget’s Disease
|
Reid, N. |
|
|
2 |
S1 |
p. |
artikel |
185 |
Squamoid Eccrine Ductal Carcinoma: A Case Series of Three Patients
|
Tudurachi, I. |
|
|
2 |
S1 |
p. |
artikel |
186 |
Staging of Mucosal Melanoma of the Head and Neck
|
Jeong, Y.J. |
|
|
2 |
S1 |
p. |
artikel |
187 |
Stratified processing of skin lesions through deep learning
|
Clauwaert, V. |
|
|
2 |
S1 |
p. |
artikel |
188 |
Sun awareness and prevention in chemotherapy patients: a comparative study
|
Stennevin, A. |
|
|
2 |
S1 |
p. |
artikel |
189 |
Sun Protection Patterns Among Organ Transplant Recipients and Non-Organ Transplant Patients with Skin Cancers
|
Oh, C.C. |
|
|
2 |
S1 |
p. |
artikel |
190 |
Surgical treatment of external ear skin melanoma: literature review and one-center experience
|
Kukushkina, M. |
|
|
2 |
S1 |
p. |
artikel |
191 |
Survival Outcomes in T3N0 versus N1 in Head and Neck Cutaneous Squamous Cell Carcinoma – Implications for Neoadjuvant Immune Checkpoint Inhibitor Immunotherapy
|
Yung, A.E. |
|
|
2 |
S1 |
p. |
artikel |
192 |
Targeting autophagy as a therapeutic intervention in BRAFV600E melanoma cells through ULK-1 inhibition
|
Ríos Martínez, C. |
|
|
2 |
S1 |
p. |
artikel |
193 |
Tebentafusp effect on the tumoural landscape in metastatic uveal melanoma – a post-mortem study
|
Beland, C. |
|
|
2 |
S1 |
p. |
artikel |
194 |
The clinical utility of comprehensive genomic profiling tests for patients with advanced malignant melanoma in a real-world setting: A retrospective analysis from a single cancer center
|
Matsui, Y. |
|
|
2 |
S1 |
p. |
artikel |
195 |
The Correlation Between Clinical and Pathological Tumor Size in Cutaneous Squamous Cell Carcinoma and the Risk of Erroneous Downstaging
|
Ceran, M. |
|
|
2 |
S1 |
p. |
artikel |
196 |
The Dutch Early-Stage Melanoma Study (D-ESMEL): a Discovery Set and Validation Cohort to Predict the Absolute Risk of Distant Metastases in Stage I/II Cutaneous Melanoma
|
Zhou, C. |
|
|
2 |
S1 |
p. |
artikel |
197 |
The Dutch Keratinocyte Cancer Collaborative: real-world linked health care data to identify and follow-up patients with advanced cutaneous squamous carcinoma on a nationwide level
|
Eggermont, C. |
|
|
2 |
S1 |
p. |
artikel |
198 |
The health economic impact of the 31-gene expression profile test for treatment and surveillance management plans in patients with cutaneous melanoma
|
Zakria, D. |
|
|
2 |
S1 |
p. |
artikel |
199 |
The interest of dermascopy X400 technique interpreted by non dermatologists and an artificial intelligence software in the identification of pigmented genital lesions
|
Bruet, M. |
|
|
2 |
S1 |
p. |
artikel |
200 |
The practice of using Vacuum-Assisted Closure in combination with free skin grafts in the treatment of wound defects after removal of malignant skin neoplasms
|
Ostafiichuk, V. |
|
|
2 |
S1 |
p. |
artikel |
201 |
The risk of subsequent skin cancer in patients with atypical fibroxanthoma or pleomorphic dermal sarcoma compared to the general population: a retrospective cohort study
|
van der Waa, J. |
|
|
2 |
S1 |
p. |
artikel |
202 |
The RoMEO study: a real-world, observational, prospective investigation of dabrafenib and trametinib combination treatment in patients with BRAF V600 unresectable or metastatic cutaneous melanoma
|
Mortier, L. |
|
|
2 |
S1 |
p. |
artikel |
203 |
The treatment of elderly patients with locally advanced or metastatic cutaneous squamous cell carcinoma using Cemiplimab monotherapy or Cemiplimab associated with palliative radiotherapy: A single centre experience from the United Kingdom
|
del Carpio Barreda, A. |
|
|
2 |
S1 |
p. |
artikel |
204 |
The use of High Frequency Ultrasound in Cutaneous Oncology Surgery
|
Tovo, L.F. |
|
|
2 |
S1 |
p. |
artikel |
205 |
Time interval between Sentinel Lymph Node Biopsy and Excision of Primary Melanoma does not impact long term outcomes in a large UK cohort
|
Kounidas, G. |
|
|
2 |
S1 |
p. |
artikel |
206 |
Title: Survival Analysis of Patients with Non-Cutaneous Metastatic Melanoma Treated in a Reference Center in Northeast Mexico
|
Guel, T. |
|
|
2 |
S1 |
p. |
artikel |
207 |
Topical Rhenium-188 ionizing radiation therapy exerts high efficacy in curing non-melanoma skin cancer- Final study results
|
Tietze, J.K. |
|
|
2 |
S1 |
p. |
artikel |
208 |
Total skin micrografts with punch for repair of surgical defects in acral skin
|
Vargas, P. |
|
|
2 |
S1 |
p. |
artikel |
209 |
Tumor microenvironment (TME) features and serum cytokines in patients with metastatic uveal and cutaneous melanoma treated with tebentafusp
|
Hamid, O. |
|
|
2 |
S1 |
p. |
artikel |
210 |
Ultrasonography for the diagnosis and follow-up of extramammary Paget's disease (EMPD). A case-report
|
Sánchez-Puigdollers, A. |
|
|
2 |
S1 |
p. |
artikel |
211 |
Unlocking Potential in Clinical Practice: A Comprehensive Assessment of an Artificial Intelligence Based Clinical Decision Support System for Cutaneous Melanoma Detection
|
Papachristou, P. |
|
|
2 |
S1 |
p. |
artikel |
212 |
Unraveling the Impact of Microbiome on Immunotherapy Efficacy in Melanoma
|
Bagué Companys, J. |
|
|
2 |
S1 |
p. |
artikel |
213 |
Unresectable endocrine mucin-producing sweat gland carcinoma revealing an actionable somatic CHEK2 gene mutation
|
Tzoumpa, S. |
|
|
2 |
S1 |
p. |
artikel |
214 |
Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France
|
Dalle, S. |
|
|
2 |
S1 |
p. |
artikel |
215 |
Updates on CTCL diagnostic and therapeutic trends amidst the COVID-19 pandemic: insights from a referral center
|
Roccuzzo, G. |
|
|
2 |
S1 |
p. |
artikel |
216 |
Usability of a smartphone app for skin cancer detection
|
Kips, J. |
|
|
2 |
S1 |
p. |
artikel |
217 |
Use of 3-dimensional total body photography and digital dermoscopy with artificial intelligence algorithms for early melanoma detection in high-risk patients
|
Serra-García, L. |
|
|
2 |
S1 |
p. |
artikel |
218 |
Use of Immune Checkpoint Inhibitor (ICI) Therapy for Cutaneous Melanoma from 2014 to 2021 in Norway: Insights from Real-World Data
|
Reis Costa, D. |
|
|
2 |
S1 |
p. |
artikel |
219 |
Using a clinicopathologic and gene expression model to predict prognosis in stage I-II primary cutaneous melanoma: a multicenter Danish cohort study
|
Weitemeyer, M.B.-M. |
|
|
2 |
S1 |
p. |
artikel |
220 |
Using the free flap to repair the postoperative defect of the head and neck squamous cell carcinomaUsing the free flap to repair the postoperative defect of the head and neck squamous cell carcinoma
|
Sun, Y. |
|
|
2 |
S1 |
p. |
artikel |
221 |
Validation of the Melanoma Institute Australia Prediction Tool for Sentinel Node Metastasis Risk Amongst Patients with Cutaneous Head and Neck Melanoma
|
Li, A.T. |
|
|
2 |
S1 |
p. |
artikel |
222 |
What is the quality-of-life impact of basal cell carcinoma in older patients? A multicentric cross-sectional study
|
Van Coile, L. |
|
|
2 |
S1 |
p. |
artikel |
223 |
Whole transcriptome sequencing: Optimizing molecular classification and management of rare skin cancers
|
Louveau, B. |
|
|
2 |
S1 |
p. |
artikel |